Dale H. Conaway, Director at Boston Therapeutics, Inc. (BTHE), bought 5,000 shares at $0.12 ($600) on 2015-05-15, disclosed to the SEC on 2015-06-08.
Open-market purchase of $600 BTHE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PRW | BUY | 2007-03-08 | $2K | — | Filing → |
| PRW | BUY | 2007-02-09 | $3K | — | Filing → |